Aberrant activation of the Hedgehog (Hh) signaling pathway contributes to many forms of cancer. Primary cilia are Hh signal transduction centers. Two papers in a recent issue of Nature Medicine (Han et al., 2009; Wong et al., 2009) show that mutating cilia can increase or reduce the rates of tumorigenesis depending on how the Hh pathway is disrupted.
In a victory for a small and once neglected organelle, two papers recently published in Nature Medicine now demonstrate that brain and skin tumors dependent on Hedgehog (Hh) signaling are regulated by primary cilia (Han et al., 2009; Wong et al., 2009 ). Erudite cell biologists have known for a long while that most cell types in our bodies have these singular immotile appendages (Berbari et al., 2009) . Genetic damage to primary cilia results in a spectrum of problems classified as ciliopathies. The diseases can have a range of effects, including blindness and improper brain development (Sharma et al., 2008) . Primary cilia are important for proper Hh signaling (Figure 1 ), and at least some ciliopathy-associated problems can now be attributed to disrupted Hh signal transduction.
Motile cilia have familiar active physiologic roles, such as clearing air passages and moving cerebrospinal fluid through ventricles in the brain. In contrast, primary cilia are moved rather than movers, transducing signals in response to fluid flow in kidneys or in response to mechanical bone deformation. Cilia consist of a plasma membrane sheath containing a microtubule-based axoneme with nine peripheral microtubule doublets and no central pair of microtubules. The axoneme extends from the basal body, which arises from a centriole taking time off from cell division. When cells reenter the cell cycle, the centriole must return to its role in cell division, and primary cilia are disassembled. These intermittently present cell-surface organelles contain a rich collection of proteins, as well as mysteries.
Kif3a and Ift88 encode cilium components. Kif3a encodes a kinesin that is employed for transport along the microtubule axoneme from the base of cilia toward their tips. Because protein synthesis does not occur in cilia, this anterograde transport is crucial in formation and maintenance of the organelle. Mice lacking Kif3a function lack cilia, die early in embryonic development, and exhibit deficient left-right patterning (Marszalek et al., 1999) . Ift88 encodes a component of the intraflagellar transport machinery that is required for cilium formation. Ift88 protein is present in basal bodies and cilia in nondividing cells, and in centrosomes during cell division (Robert et al., 2007) . Mice lacking Ift88 function die in midgestation. Their defects include left-right asymmetry, cilium malformation, and neuraltube abnormalities (Murcia et al., 2000) .
Key features of Hh signaling were initially worked out in Drosophila, an organism in which Hh-transducing cells lack primary cilia. Appreciation of the involvement of cilia in vertebrate Hh signaling has provoked new questions about cell biology mechanisms. When Hh pathway restraint systems are damaged, cancer can arise in tissues where Hh target genes normally stimulate cell division. The Hh pathway was first connected to cancer when Gorlin syndrome was found to be due to loss of Ptc receptor function. Loss of Ptc function allows Smo activity to go unchecked, thus leading to excessive activation of Hh target genes that promote cell division. The consequences, in Gorlin syndrome, include basal cell carcinoma (BCC) of the skin and medulloblastoma (MB) of the cerebellum, as well as skeletal and other defects.
The two new papers exploit another route to tumorigenesis-constitutively The skin and tumors of these mice had few cilia, as expected. The Gli2 transcription factor acts downstream of Smo in the skin, so the authors further investigated the role of Kif3a in tumorigenesis, using a mouse model employing inducible constitutively active Gli2 with a mutation in the N-terminal repressor domain of the protein (Gli2DN). Gli2DN, behaving as a constitutively active protein, raises the levels of endogenous Gli2. Here came the big surprise: tumorigenesis was accelerated in the absence of cilia. Evidently, cilia can normally restrain the activity of this abnormal form of Gli2. The use of Gli2DN makes the implications for typical tumorigenesis unclear, but the results could imply that sequestration of normal Gli2 in cilia limits its ability to go off and cause trouble in the nucleus. Cilia are also needed to generate a repressing form of Gli3 (GliR).
Thus, Gli3R may restrain Gli2DN in ciliated cells. When cilia are not formed, Gli3R cannot be produced and Gli2DN has added destructive potency. How Gli2DN interacts with normal Gli proteins is unclear.
The second paper applies a similar strategy to the analysis of MB, a less frequent but more deadly tumor often seen in Gorlin syndrome patients. The paper reports the presence of cilia in human MBs. To test the roles of cilia in MB, Han and Von Hoff et al., 2009; Yauch et al., 2009 ). The two recent Nature Medicine papers highlight the intriguing potential of primary cilia components as alternative targets for antitumor drugs, but they underscore the challenges of manipulating an organelle that has positive and negative effects on pathway activity and tumorigenicity. 
